Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I P Everall

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Molecular Psychiatry|July 26, 2002
Density and distribution of white matter neurons in schizophrenia, bipolar disorder and major depressive disorder: no evidence for abnormalities of neuronal migrationC L Beasley, D R Cotter, I P Everall
Lancet (London, England)|May 11, 1991
Neuronal loss in the frontal cortex in HIV infectionI P Everall, P J Luthert, P L Lantos
Glia|December 18, 2001
Expression of beta-chemokines and chemokine receptors in human fetal astrocyte and microglial co-cultures: potential role of chemokines in the developing CNSP Rezaie, G Trillo-Pazos, I P Everall, et al.
Schizophrenia Research|March 9, 2000
Increased dendritic MAP2 expression in the hippocampus in schizophreniaD Cotter, S Wilson, E Roberts, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|October 15, 2013
Effects of neuregulin-1 genetic variation and depression symptom severity on longitudinal patterns of psychotic symptoms in primary care attendeesC A Bousman, M Potiriadis, I P Everall, et al.
Journal of Neuroscience Research|February 25, 2000
Fibroblast growth factor modulates HIV coreceptor CXCR4 expression by neural cells. HNRC GroupV J Sanders, I P Everall, R W Johnson, et al.
Acta Neuropathologica|January 1, 1994
Neuronal density in the superior frontal and temporal gyri does not correlate with the degree of human immunodeficiency virus-associated dementiaI P Everall, J D Glass, J McArthur, et al.
Brain Research|August 15, 1997
Alterations in hippocampal non-phosphorylated MAP2 protein expression in schizophreniaD Cotter, R Kerwin, B Doshi, et al.
Molecular Psychiatry|March 1, 2003
The axonal chemorepellant semaphorin 3A is increased in the cerebellum in schizophrenia and may contribute to its synaptic pathologyS L Eastwood, A J Law, I P Everall, et al.
Molecular Psychiatry|January 15, 2014
Response to Belgard et alE Skafidas, R Testa, D Zantomio, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Molecular Psychiatry|July 26, 2002
Density and distribution of white matter neurons in schizophrenia, bipolar disorder and major depressive disorder: no evidence for abnormalities of neuronal migrationC L Beasley, D R Cotter, I P Everall
Lancet (London, England)|May 11, 1991
Neuronal loss in the frontal cortex in HIV infectionI P Everall, P J Luthert, P L Lantos
Glia|December 18, 2001
Expression of beta-chemokines and chemokine receptors in human fetal astrocyte and microglial co-cultures: potential role of chemokines in the developing CNSP Rezaie, G Trillo-Pazos, I P Everall, et al.
Schizophrenia Research|March 9, 2000
Increased dendritic MAP2 expression in the hippocampus in schizophreniaD Cotter, S Wilson, E Roberts, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|October 15, 2013
Effects of neuregulin-1 genetic variation and depression symptom severity on longitudinal patterns of psychotic symptoms in primary care attendeesC A Bousman, M Potiriadis, I P Everall, et al.
Journal of Neuroscience Research|February 25, 2000
Fibroblast growth factor modulates HIV coreceptor CXCR4 expression by neural cells. HNRC GroupV J Sanders, I P Everall, R W Johnson, et al.
Acta Neuropathologica|January 1, 1994
Neuronal density in the superior frontal and temporal gyri does not correlate with the degree of human immunodeficiency virus-associated dementiaI P Everall, J D Glass, J McArthur, et al.
Brain Research|August 15, 1997
Alterations in hippocampal non-phosphorylated MAP2 protein expression in schizophreniaD Cotter, R Kerwin, B Doshi, et al.
Molecular Psychiatry|March 1, 2003
The axonal chemorepellant semaphorin 3A is increased in the cerebellum in schizophrenia and may contribute to its synaptic pathologyS L Eastwood, A J Law, I P Everall, et al.
Molecular Psychiatry|January 15, 2014
Response to Belgard et alE Skafidas, R Testa, D Zantomio, et al.
Pageof 7